Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 1:39 PM UTC
| NCT Number | NCT06607627 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 12 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | April 1, 2026 (Apr 1, 2026) |
As of July 20, 2026: Clinical trial NCT06607627 is currently recruiting participants. This phase3 study for myasthenia gravis is actively seeking new participants at 2 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06607627 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06607627 was last updated Apr 1, 2026 (April 1, 2026). HelloStudys verifies this status automatically.